Seagen Inc Formerly Known As Seattle Geneticsis A Prominent American Biotechnology Company Based In Bothellwashingtonfounded In 1997Seagen Specializes In Developing And Commercializing Monoclonal Antibody Based Therapies For Cancer Treatmentthe Company Is Recognized For Its Pioneering Work In Antibody Drug Conjugatesadcs Which Effectively Target Cancer Cells While Minimizing Damage To Healthy Cells Seagen S Product Lineup Includes Adcetris For Hodgkinae S Lymphoma And Other Lymphomaspadcev For Metastatic Urothelial Cancerstukysa For Her2 Positive Breast Cancersand Tivdak For Certain Metastatic Cervical Cancersthe Company Is Committed To Addressing Unmet Medical Needs In Oncology Through Its Innovative Therapies And Ongoing Research And Development Effortsseagen Operates As A Subsidiary Of Pfizerreflecting A Strong Partnership Aimed At Advancing Cancer Treatment Solutions
